MPLT (STOCKS)
MapLight Therapeutics, Inc. Common Stock
$11.980000
+0.400000 (+3.45%)
Prev close: $11.580000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christopher A. Kroeger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $499.70M
- Employees
- 133
- P/E (TTM)
- -2.29
- P/B (TTM)
- 1.53
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
11
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.34 | $-1.12 | -0.2247 | -20.15% |
|
Dec 2025 (Q4)
|
$-2.47 | $-0.98 | -1.4888 | -151.73% |
|
Sep 2025 (Q3)
|
$-37.18 | $-1.76 | -35.4205 | -2,013.10% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $242.93M |
| Research and Development | $198.84M |
| Other Operating Expenses | $44.09M |
| Operating Income/Loss | -$242.93M |
| Income/Loss From Continuing Operations After Tax | -$229.83M |
| Income/Loss From Continuing Operations Before Tax | -$229.83M |
| Net Income/Loss | -$229.83M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$229.83M |
| Net Income/Loss Available To Common Stockholders, Basic | -$229.83M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $47.24 |
| Diluted Earnings Per Share | $47.24 |
| Basic Average Shares | 53,272,904 |
| Diluted Average Shares | 53,272,904 |
| Assets | $368.35M |
| Current Assets | $318.79M |
| Noncurrent Assets | $49.56M |
| Fixed Assets | $828.00K |
| Other Non-current Assets | $48.73M |
| Liabilities | $20.05M |
| Current Liabilities | $19.29M |
| Accounts Payable | $2.05M |
| Wages | $4.87M |
| Other Current Liabilities | $12.38M |
| Noncurrent Liabilities | $755.00K |
| Equity | $348.30M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $348.30M |
| Liabilities And Equity | $368.35M |
| Net Cash Flow From Operating Activities | -$174.67M |
| Net Cash Flow From Operating Activities, Continuing | -$174.67M |
| Net Cash Flow From Investing Activities | -$250.43M |
| Net Cash Flow From Investing Activities, Continuing | -$250.43M |
| Net Cash Flow From Financing Activities | $463.26M |
| Net Cash Flow From Financing Activities, Continuing | $463.26M |
| Net Cash Flow | $38.17M |
| Net Cash Flow, Continuing | $38.17M |
| Comprehensive Income/Loss | -$230.82M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$230.82M |
| Other Comprehensive Income/Loss | -$230.82M |